controversy
Mylan latest target of US anger on drug pricing with EpiPen price increase
August 24, 2016Research and Development, Sales and Marketing Mylan, US, congress, controversy, epipen, price gouging, price increase
The US congress is again subjecting the pharmaceutical industry to heavy scrutiny over drug pricing policies with Mylan its latest …
Valeant ends controversial litigation with R&O Pharmacy
March 10, 2016Litigation, Philidor, Valeant, controversy, r&o pharmacy, scandal
Valeant has announced that, in conjunction with R&O Pharmacy, its has jointly requested that the Court dismiss the litigation between …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
